Delivery Order SPE2DB20D2014-SPE2DB26FA15A
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,701.73 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300mL volume. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is to be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (300mL) with a ceiling value of $1,154.53. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300 mL quantity, with a firm fixed price ceiling value of $1,427.88. This non-competitive delivery order, which has an ultimate completion date of September 11, 2025, falls under the Medical Supply Chain division of the Department of Defense. The award represents a child contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a $317,823.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, with completion scheduled for June 17, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (150 mL) with a firm fixed price ceiling value of $1,332.16. This non-set-aside competitive award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $385,020.34 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $45,177.29 by the Defense Logistics Agency's Medical Supply Chain on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA15ADelivery Order
The Defense Logistics Agency awarded a $1,772.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/ml oral suspension (150ml), with an ultimate completion date of October 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order exemplifies AmerisourceBergen's extensive role as a prime vendor within the DLA's Medical Supply Chain, supplying a comprehensive range of pharmaceutical products across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical procurement requirements through competitive awards with firm fixed pricing structures. As DLA Troop Support advances its Pharmaceutical Prime Vendor Global Program Generation V initiative, which plans multiple regional awards among select contractors, AmerisourceBergen's established performance and substantial contract vehicle position it as a key pharmaceutical supplier for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/21/25 |